Market Size of North America Cardiac Monitoring Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
Forecast Data Period | 2024 - 2029 |
Market Size (2024) | USD 11.96 Billion |
Market Size (2029) | USD 15.57 Billion |
CAGR (2024 - 2029) | 5.43 % |
Major Players*Disclaimer: Major Players sorted in no particular order |
North America Cardiac Monitoring Market Analysis
The North America Cardiac Monitoring Market size is estimated at USD 11.96 billion in 2024, and is expected to reach USD 15.57 billion by 2029, growing at a CAGR of 5.43% during the forecast period (2024-2029).
The COVID-19 pandemic slowed the growth of the cardiac monitoring market. Due to the high rate of infection and the lack of treatment, many countries had previously shut down and stopped trading with other countries due to travel restrictions, leading to a slowdown for large companies worldwide. Furthermore, according to an article published by BMJ Journals in April 2021, a study was conducted in Europe, which showed that the COVID-19 pandemic significantly impacted the care of patients with cardiac diseases. Therefore, the market was significantly impacted during the early COVID-19 period. However, as the pandemic has subsided, the studied market is expected to have decent growth over the forecast period of study.
In addition, the rising burden of cardiovascular diseases, advancements in technology, and demand for home-based, point-of-care, and remote-monitoring cardiac systems are actively affecting the growth of the studied market. According to the data published by Statistics Canada in July 2022, it is estimated that around 7,330,605 people are aged 65 years or older in Canada, and this accounts for 18.8% of the total population. As the geriatric population is at high risk of cardiovascular diseases, the increasing geriatric population in the region is also boosting the market's growth.
The technological advancements in cardiac monitoring devices, product launches, partnerships, and acquisitions are projected to boost the market growth. For instance, in January 2021, Boston Scientific Corporation acquired Preventice Solutions, a privately held company that provides a full range of mobile cardiac health solutions and services, including ambulatory cardiac monitors like short- and long-term Holter monitors, cardiac event monitors, and mobile cardiac telemetry. Also, in February 2021, Philips acquired Biotelemetry Inc., the United States-based provider of remote cardiac diagnostics and monitoring. The acquisitions are expected to boost the market growth.
Furthermore, in July 2021, Abbott launched Jot Dx in the United States. It is an insertable cardiac monitor (ICM). The Jot Dx ICM provides clinicians and hospitals efficient control of how they manage the flow of information through a unique feature to view all abnormal heart rhythm data or simplify which irregular heart rhythms are recorded with a "key episodes" option. This innovative technology allows for remote detection and improved diagnostic accuracy of cardiac arrhythmia in patients.
Therefore, owing to the factors mentioned above, such as the increasing geriatric population associated with rising cardiovascular diseases, and the product launches, partnerships, and acquisitions, the studied market is anticipated to witness growth over the analysis period. However, the risk of infection due to implantable monitoring devices and unfavorable reimbursement policies is likely to impede the market growth.
North America Cardiac Monitoring Industry Segmentation
As per the scope of the report, cardiac monitoring is an important tool for the clinical assessment of patients, with a variety of conditions. It allows the detection of changes in heart rate and rhythm and is essential for detecting life-threatening arrhythmias. This is achieved using a cardiac monitor, connected to a cable lead and skin electrodes, which captures the electrical activity, predominantly through a single view. The North American Cardiac Monitoring market is segmented by Device Type (ECG Monitor, Event Recorder, Implantable Cardiac Loop Recorder, Pacemaker, Defibrillator, Cardiac Resynchronization Therapy (CRT) Devices, Smart Wearable, and Other Device Types), End User (Hospitals and Clinics, Home Care Settings, and Ambulatory Surgical Centers), and Geography (United States, Canada, and Mexico). The report offers the value (in USD million) for the above segments.
By Device Type | |
ECG Monitor | |
Event Recorder | |
Implantable Cardiac Loop Recorder | |
Pacemaker | |
Defibrillator | |
Cardiac Resynchronization Therapy (CRT) Devices | |
Smart Wearable | |
Other Device Types |
By End User | |
Hospitals and Clinics | |
Home Care Settings | |
Ambulatory Surgical Centers |
Geography | |
United States | |
Canada | |
Mexico |
North America Cardiac Monitoring Market Size Summary
The North American cardiac monitoring market is poised for significant growth over the forecast period, driven by a combination of factors including the rising prevalence of cardiovascular diseases and advancements in technology. The market, which experienced a slowdown due to the COVID-19 pandemic, is expected to recover and expand as the demand for home-based, point-of-care, and remote-monitoring systems increases. The growing geriatric population, particularly in countries like Canada and the United States, is further propelling market growth, as this demographic is at a higher risk for cardiovascular conditions. Technological innovations, such as the development of insertable cardiac monitors and leadless pacemakers, along with strategic partnerships and acquisitions by key industry players, are also contributing to the market's expansion.
The United States is anticipated to hold a significant share of the market, supported by a robust healthcare infrastructure, a high concentration of industry players, and increased awareness of available technologies. The presence of major companies like Abbott Laboratories, Boston Scientific Corporation, and Medtronic PLC, along with their ongoing product launches and clinical trials, is expected to drive market growth in the region. Despite challenges such as the risk of infection from implantable devices and unfavorable reimbursement policies, the market is set to benefit from the continuous advancements in cardiac monitoring technologies and the increasing demand for effective cardiac care solutions. The competitive landscape remains fragmented, with both international and local companies vying for market share, indicating a dynamic and evolving industry environment.
North America Cardiac Monitoring Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Burden of Cardiovascular Diseases
-
1.2.2 Advancements in Technology
-
1.2.3 Demand for Home-based, Point of Care, and Remote Monitoring Cardiac Systems
-
-
1.3 Market Restraints
-
1.3.1 Risk of Infection Due to Implantable Monitoring Devices
-
1.3.2 Unfavourable Reimbursement Policies
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value - USD million)
-
2.1 By Device Type
-
2.1.1 ECG Monitor
-
2.1.2 Event Recorder
-
2.1.3 Implantable Cardiac Loop Recorder
-
2.1.4 Pacemaker
-
2.1.5 Defibrillator
-
2.1.6 Cardiac Resynchronization Therapy (CRT) Devices
-
2.1.7 Smart Wearable
-
2.1.8 Other Device Types
-
-
2.2 By End User
-
2.2.1 Hospitals and Clinics
-
2.2.2 Home Care Settings
-
2.2.3 Ambulatory Surgical Centers
-
-
2.3 Geography
-
2.3.1 United States
-
2.3.2 Canada
-
2.3.3 Mexico
-
-
North America Cardiac Monitoring Market Size FAQs
How big is the North America Cardiac Monitoring Market?
The North America Cardiac Monitoring Market size is expected to reach USD 11.96 billion in 2024 and grow at a CAGR of 5.43% to reach USD 15.57 billion by 2029.
What is the current North America Cardiac Monitoring Market size?
In 2024, the North America Cardiac Monitoring Market size is expected to reach USD 11.96 billion.